Press Releases & Presentations

 
(Swipe to view full table)
  Date Title and Summary View

Jul 1, 2013

Accelerate Diagnostics Appoints Chief Commercial Officer
TUCSON, Ariz., July 1, 2013 /PRNewswire/ -- Accelerate Diagnostics, Inc. (AXDX), today announced that it has appointed Pete Bantock to the position of Chief Commercial Officer, effective today.Most recently Pete was Sr. Vice President and General Manager of Ventana Medical Systems' North American Commercial Operations. Previously, Pete...Read more

Jul 1, 2013

Accelerate Diagnostics Joins the Russell 2000® Index
TUCSON, Ariz., July 1, 2013 /PRNewswire/ -- Accelerate Diagnostics, Inc. (AXDX), an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug resistant organisms and hospital acquired infections, today announced that it has joined the Russell 2000®, Russell 3000®, and Russell Global Indexes following Russell's r...Read more

Jun 4, 2013

Accelerate Diagnostics Announces Plans For Rights Offering To Stockholders
TUCSON, Ariz., June 4, 2013 /PRNewswire/ -- Accelerate Diagnostics, Inc. (AXDX), an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug resistant organisms and hospital acquired infections, today announced that it has filed a Registration Statement on Form S-3 with the Securities and Exchange Commission (t...Read more

Mar 6, 2013

Accelerate Diagnostics, Inc. Names Frank J. M. ten Brink to Board of Directors
TUCSON, Ariz., March 6, 2013 /PRNewswire/ -- Accelerate Diagnostics, Inc. (AXDX), a developer of automated diagnostic systems for same-shift identification and antibiotic resistance testing of bacterial and fungal pathogens, announced today that Frank J.M. ten Brink has been appointed to its board of directors.Mr. ten Brink has more tha...Read more

Dec 12, 2012

Accelerate Diagnostics goes to NASDAQ
DENVER, Dec. 12, 2012 /PRNewswire/ -- Accelr8 Technology Corporation (NYSE MKT: AXK) announced today that its common stock has been approved by The NASDAQ Stock Market, LLC for listing on the NASDAQ Capital Market. The Company expects to commence trading on NASDAQ under the ticker symbol "AXDX" on Wednesday, December 26, 2012. Until such date, th...Read more

Jun 27, 2012

Accelr8 Announces New Management
Denver, Co., June 26, 2012 – Accelr8 Technology Corporation (NYSE MKT: AXK) today announced the appointment of Lawrence Mehren as President and Chief Executive Officer and a member of the Board of Directors. Most recently, Mr. Mehren was Head of Global Business of Ventana Medical Systems and Roche Tissue Diagnostics, managing its four busi...Read more

Jun 26, 2012

Accelr8 Closes on Investment
Denver, Co., June 26, 2012 – Accelr8 Technology Corporation (NYSE MKT: AXK) announced today that it has received shareholder approval, met all closing conditions, and has consummated a transaction that will result in an investment of up to $35 million in Accelr8's common stock. The purpose is to complete the product development and market ...Read more

Jun 22, 2012

Accelr8 Presents Two Studies at ASM 2012 and Receives Acceptance to Present a New Blood Study
Denver, Co., June 22, 2012 – Accelr8 Technology Corporation (NYSE MKT: AXK) announced results of two studies that it presented at the 112th annual General Meeting of the American Society for Microbiology (www.asm.org). The first study used the company's BACcel™ rapid automated diagnostic system with positive blood cultures to detect a...Read more

May 15, 2012

Accelr8 and Denver Health Notified by Department of Defense for Rapid Diagnostics Award
DENVER, Colo., May 15, 2012 – Accelr8 Technology Corporation (NYSE MKT: AXK) and Denver Health received notice that the Defense Medical Research and Development Program (DMRDP) recommended $2 million funding of a proposed 35-month project submitted jointly by Denver Health and Accelr8. The DMRDP solicited proposals to "advance state-of-the...Read more

Apr 23, 2012

Accelr8 Attracts Up To $35 Million Private Equity Investment
DENVER, Colo., April 23, 2012 – Accelr8 Technology Corporation (Amex: AXK) announced today that an investment group formed by Jack Schuler, John Patience, and Larry Mehren will invest a total of up to $35 million in Accelr8's common stock. The purpose is to complete the product development and market introduction of Accelr8's BACcel™ ...Read more
FirstPrevious
1
...
4
5
6
7
8
Next Last

= add release to Briefcase
NASDAQ: AXDX
$ 26.30
+0.25
(0.96%)
4:00 PM ET on Nov 22, 2017
Day High: 26.60
Day Low:  25.90
Volume:    765,709
Delayed ~20 min., by eSignal.

Want to receive investor-related news and updates?

Join our mailing list

Other updates